Insight & acceleration of clinical trials across multiple study types

How it works in practice :

​​

• Continuous tracking of heart rate, blood pressure, oxygen saturation, glucose, sleep, and activity enables early detection of changes.

• Trial teams can intervene proactively, reduce missing data, and adjust dosing when needed.

• Participants benefit from fewer clinic visits, personalized health insights, and reassurance that their wellbeing is monitored.

Supporting remote participation:
 

• Vital signs, activity, sleep, and patient-reported outcomes are captured from home.

• AI-driven alerts help trial teams detect risk or non-compliance early.

• Participants experience lower travel burdens, while sponsors gain rich real-world behavioral data.

Optimizing therapy and safety:
 

• Continuous monitoring captures PK/PD biomarkers and vital signs in real time.

• Early detection of subclinical drug effects informs adaptive dosing and regulatory documentation.

• Participants benefit from safer, personalized dosing and a deeper understanding of their treatment response.

Understanding daily function:
 

• Activity, sleep, and mobility patterns are continuously monitored, revealing subtle changes in function.

• Early interventions are triggered when declines are detected, supporting better trial outcomes.

• Participants receive feedback that motivates engagement, reduces risk, and preserves independence.

Protecting participants:

​

• Continuous telemetry monitors heart rhythm, oxygen saturation, respiratory function, and glucose.

• Alerts notify trial teams immediately if deviations are detected.

• Participants gain reassurance and real-time support, while trial sponsors reduce risk and strengthen regulatory confidence.